Laurie Stelzer

Laurie serves as a board member to Sionna and is Chief Financial Officer of Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the treatment of obesity and related conditions. She also currently serves on the board of PMV Pharmaceuticals, Inc. and Spyre Therapeutics, Inc. Laurie has over 25 years of finance and business development leadership experience in the biopharmaceutical industry. She has held leadership roles in finance, treasury, global accounting, business development, project management, and site operations for a range of biopharmaceutical companies including as Chief Financial Officer of Orna Therapeutics, Mirati Therapeutics, Inc., Arena Pharmaceuticals, Inc., and Halozyme Therapeutics, Inc. She also held senior management roles at Shire Plc and Amgen, Inc., and previously served on the board of Surface Oncology, Inc. and Longboard Pharmaceuticals. Laurie earned a B.S. in Accounting from Arizona State University and an M.B.A. from University of California, Los Angeles, Anderson School of Management.